webfact Posted November 30, 2022 Share Posted November 30, 2022 BANGKOK, Nov 30 (TNA) – New guidelines for the Covid-19treatment, put into effect today will adjust dispensing of anti-viral drug and increase the use of Long Acting Antibody (LAAB) for vulnerable patients with underlying health conditions. Director–General of the Department of Medical Services, Dr.Thongchai Keeratihattayakorn said that the new guidelines for the Covid-19 treatment, to be applied by medical personnel have been revised. There are changes in dispensing anti-viral drug for Covid-19 treatment and more LAAB treatment will be used in patients at risk of complications. Under the new guidelines, Favipiravir is used in pediatric patients, Molnupiravir for patients with mild symptoms and Paxlovid for patients with pneumonia and low oxygen level. Full story: https://tna.mcot.net/english-news-1067347 -- © Copyright Thai News Agency 2022-11-30 - Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here. Monthly car subscription with first-class insurance, 24x7 assistance and more in one price - click here to find out more! Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now